In these cancers, some established tumor suppressive genes were found to be the direct targets of miR-144, such as PTEN in nasopharyngeal carcinoma (Song et al., 2019), and ARID1A in clear cell renal cell carcinoma (Xiao et al., 2017). This evidence concerns the gene ARID1A and neoplasm.